Armistice Capital’s Dogwood Therapeutics DWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DWTX
Armistice Capital's DWTX Position: Q3 2026 in Review
Armistice Capital reduced its Dogwood Therapeutics (DWTX) stake by 5.6% in Q3 2026, selling an estimated $314K and leaving 2,958,171 shares worth $3.99M. The position accounts for 0.05% of the portfolio, ranked #129.
Armistice Capital first reported a position in DWTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.92M in Q1 2026. 22 funds tracked by Wall St. Rank hold DWTX as of Q3 2026.
- Armistice Capital held 2,958,171 shares of Dogwood Therapeutics worth $3.99M as of Q3 2026.
- Armistice Capital sold 174,315 Dogwood Therapeutics shares in Q3 2026, an estimated $314K.
- Dogwood Therapeutics made up 0.05% of Armistice Capital's portfolio in Q3 2026, its #129 holding.
- Armistice Capital first reported a position in Dogwood Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Armistice Capital's Dogwood Therapeutics position peaked at $6.92M in Q1 2026.
- 22 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2026.
Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.